John Hess

John Hess is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Senior Vice President for the Americas and Head of North America at Chiesi Global Rare Diseases since January 2020, Hess previously held the role of Head of Commercial Operations for Rare Diseases at Apobiologix, which was acquired by Chiesi. John's earlier tenure at Daiichi Sankyo Inc. spanned nearly two decades, where Hess notably contributed as the National Director of Oncology, leading the sales organization for ZELBORAF and playing a core role in the PLX3397 Global New Product Team. Hess's extensive background includes positions such as West Area Business Director, West Regional Sales Director, and Senior Sales Manager at Daiichi Sankyo, as well as experience as a Specialty Medical Representative at Roberts Pharmaceutical Corporation. Educational credentials include degrees from Ohio Wesleyan University, INSEAD, and Thayer Leadership.